1. A population‐based study of factors associated with systemic treatment in advanced prostate cancer decedents. (17th November 2022) Authors: Leigh, Jennifer; Qureshi, Danial; Sucha, Ewa; Mahdavi, Roshanak; Kushnir, Igal; Lavallée, Luke T.; Bosse, Dominick; Webber, Colleen; Tanuseputro, Peter; Ong, Michael Journal: Cancer medicine Issue: Volume 12:Number 5(2023) Page Start: 5569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study. Issue 4 (April 2019) Authors: Martínez Chanzá, Nieves; Xie, Wanling; Asim Bilen, Mehmet; Dzimitrowicz, Hannah; Burkart, Jarred; Geynisman, Daniel M; Balakrishnan, Archana; Bowman, I Alex; Jain, Rohit; Stadler, Walter; Zakharia, Yousef; Narayan, Vivek; Beuselinck, Benoit; McKay, Rana R; Tripathi, Abhishek; Pachynski, Russell; ... Journal: Lancet oncology Issue: Volume 20:Issue 4(2019) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Potential insights from population kinetic assessment of progression-free survival curves. (September 2020) Authors: Stewart, David J.; Bosse, Dominick; Robinson, Andrew; Ong, Michael; Fung-Kee-Fung, Michael; Brule, Stephanie; Hilton, John F.; Ocana, Alberto Journal: Critical reviews in oncology/hematology Issue: Volume 153(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗